TAVR, Critical Care drive Edwards to Q4 sales beat
Edwards Lifesciences (NYSE: EW) shares dipped slightly today on fourth-quarter results that topped the consensus sales forecast.
Source: massdevice.com
Stay updated with breaking news from Mitris Reslia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Edwards Lifesciences (NYSE: EW) shares dipped slightly today on fourth-quarter results that topped the consensus sales forecast.